title: [The bacille Calmette-Guérin vaccine may reduce the general child morbidity].
abstract: For almost 100 years the bacille Calmette-Guérin (BCG) vaccine has been the primary prophylaxis of tuberculosis (TB). Recent studies suggest that reintroduction of the vaccine might be beneficial from a general child health perspective. Studies from West-Africa report that BCG vaccination at birth reduces child mortality and morbidity. We recently started "The Calmette Study" in Denmark to conduct a randomised clinical trial and collect firm evidence of the suggested hypothesis, that BCG vaccination at birth has beneficial unspecific effect on child health also in a high-income TB low-incidence country.
authors.affiliation: Børneafdelingen, Hvidovre Hospital, Kettegård Allé 30, 2650 Hvidovre. tnnissen@gmail.com.
authors.forename: Thomas Nørrelykke
authors.initials: TN
authors.lastname: Nissen
authors.forename: Lisbeth Marianne
authors.initials: LM
authors.lastname: Thøstesen
authors.forename: Nina Marie
authors.initials: NM
authors.lastname: Birk
authors.forename: Gitte
authors.initials: G
authors.lastname: Pihl
authors.forename: Jesper
authors.initials: J
authors.lastname: Kjærgaard
authors.forename: Lone Graff
authors.initials: LG
authors.lastname: Stensballe
mesh_terms: D001500:BCG Vaccine / Q000008:administration & dosage / Q000276:immunology* / Q000627:therapeutic use; D002648:Child; D046688:Child Mortality; D006801:Humans; D007223:Infant; D007226:Infant Mortality; D009017:Morbidity; D014376:Tuberculosis / Q000517:prevention & control
chemical_list: D001500:BCG Vaccine